In addition to earnings, Haemonetics Corp. (NYSE: HAE) announced that its Board of Directors has approved the repurchase of up ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE